Patients, patient representatives and caregivers are encouraged to attend the HTAi 2022 Annual Meeting virtually or in-person June 25-29, 2022, in Utrecht, Netherlands.
Participants can expect to meet fellow patients involved in HTA, experts in the field of HTA, and to learn about the latest developments in HTA methods and experiences.
Not sure? Please feel free to learn more about:
If you are a patient, patient representative and/or caregiver, we welcome your involvement and encourage you to register for the conference.
Need financial support to attend? Apply for financial support through our PASS program! Applications are due March 14, 2022.
CLICK HERE TO APPLY TO THE PASS PROGRAM NOW!
About the HTAi PASS Program
HTAi’s Patient and Citizen Involvement in HTA Interest Group (PCIG) has established the PASS program to provide financial and moral support to patients and their representatives (including representatives from patient organizations and HTA committees) to attend the HTAi Annual Meeting. PASS grant recipients can expect financial support for travel to/from the meeting, along with lodging and registration costs. In addition, PASS grant recipients will be joined nd supported by patients, HTAi volunteers and staff to ensure an enjoyable and valuable experience.
Repeat grant recipient’s welcome!
PCIG recognizes that patient participation at the HTAi Annual Meeting has an important role in capacity building and we value ongoing contributions and attendance. Therefore, past grant recipients are encouraged to apply and applicants should note that receiving a grant this year WILL NOT RULE YOU OUT next year.
Key dates:
March 14 2022 – PCIG PASS 2022 application deadline
March 21 2022 – Successful applicants notified by email
March 23 2022 – Deadline for applicant acceptance of award
March 24 2022 – Unsuccessful applicants notified by email
March 24 2022 – Early-bird registration deadline
June – Briefing call for successful applicants
25-29 June 2022 – HTAi Annual Meeting
Post conference – PCIG will follow up with PCIG PASS recipients to learn about their experience and make further improvements for 2023
Patient, caregiver and patient organization representatives will be selected to receive travel grants from the PCIG PASS by a subcommittee of the PCIG Steering Committee consisting of the Chair, Vice Chair and a patient representative. The funds will be administered by the HTAi Secretariat.
PCIG is grateful to Edwards Lifesciences, Janssen and Novartis for their sponsorship of these grants and commitment to patient participation in HTAi’s Annual Meeting.
htaipcigpass@gmail.com is in use only for the PCIG PASS process and should not be used for regular contact with the Interest Group or its Chair. If you have further questions, you can send them to this email and they will be answered within 48 hours. The HTAi (Health Technology Assessment International) Interest Group for Patient and Citizen Involvement Interest Group (PCIG) in health technology assessment (HTA) brings together stakeholders with an interest in the involvement of patient and citizen involvement in HTA. These stakeholders include patients, patient advocates, patient engagement consultants, clinicians, researchers, HTA agencies, government and industry.
The PCIG considers ‘involvement’, or ‘engagement’, to be a wide-ranging term that encompasses patient and citizen participation in HTA processes, and research to provide evidence about patients’ and citizens’ perspectives, preferences and experiences to input to HTA.
The PCIG sets out to ‘work together in equal partnership’. All members are considered equal and their input and feedback are equally respected. We are all committed to an overall improvement in HTA processes and the availability of equitable quality health care to improve health outcomes.